Device and drug manufacturer
S. 1413: FDA User Fee Protection Act; H.R. 2725: FDA Safety Over Sequestration Act of 2013; PL 113-67: The Bipartisan Budget Act of 2013; H.R. 3547: 2014 Consolidated Appropriations Act PHA; PL113-54: Drug Quality and Security Act; Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94) Issues relating to generic drug labeling; S. 959:  The Pharmaceutical Quality, Security and Accountability Act; H.R. 3204: The Compounding Clarity Act Issues relating to drug and nutrient shortages; P.L. 111-148: Patient Protection and Affordable Health Care Act provisions relating to biosimilar products; S. 232: Medical Device Access and Innovation Protection Act
BUD - Budget/Appropriations PHA - Pharmacy HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office
BROWN RUDNICK LLP
601 13th Street, NW, 6th Floor, Washington, DC, 20005, US
HENRY W MENN CHRISTOPHER BOWLIN LISA LAYMAN HENRY W MENN CHRISTOPHER BOWLIN LISA LAYMAN HENRY W MENN (Min SD & Counsel, Cmte on Vet Affairs (04)) LISA LAYMAN (SPA, Sen Stabenow(05-07)) CHRISTOPHER BOWLIN (Secr for Congr & Intgv Affairs, Dept. Labor 01-02)
Min SD & Counsel, Cmte on Vet Affairs (04) SPA, Sen Stabenow(05-07) Secr for Congr & Intgv Affairs, Dept. Labor 01-02